| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 367,195 | 360,671 | 453,717 | 389,964 | | Cost of Revenue | 36,340 | 45,103 | 51,927 | 65,394 | | | Gross Profit | 330,855 | 315,568 | 401,790 | 324,570 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 192,161 | 159,509 | 164,108 | 193,271 | | Non Recurring | 53,488 | 14,575 |
-
| (3,438) | | Others | (2,618) | 50,827 | 142,124 | 68,612 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 87,824 | 90,657 | 95,558 | 66,125 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 87,824 | 90,657 | 95,558 | 66,125 | | Interest Expense | 9,445 | 10,002 | 11,455 | 20,319 | | Income Before Tax | 78,379 | 80,655 | 84,103 | 45,806 | | Income Tax Expense | 24,772 | 28,315 | 28,838 | 10,363 | | Minority Interest | (3,405) | 233 | (233) |
-
| | | | Net Income From Continuing Ops | 50,202 | 52,573 | 55,032 | 35,443 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 50,202 | 52,573 | 55,032 | 35,443 | | Preferred Stock And Other Adjustments | 458 | (458) |
-
|
-
| | | Net Income Applicable To Common Shares | $50,660 | $52,115 | $55,032 | $35,443 |
|
0.02% Nasdaq 
0.33%
Income Statement
